Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Long-term neurologic and cardiac correction by intrathecal gene therapy in Pompe disease

Abstract : Pompe disease is a lysosomal storage disorder caused by acid-a-glucosidase (GAA) deficiency, leading to glycogen storage. The disease manifests as a fatal cardiomyopathy in infantile form. Enzyme replacement therapy (ERT) has recently prolonged the lifespan of these patients, revealing a new natural history. The neurologic phenotype and the persistence of selective muscular weakness in some patients could be attributed to the central nervous system (CNS) storage uncorrected by ERT. GAA-KO 6neo/6neo mice were treated with a single intrathecal administration of adeno-associated recombinant vector (AAV) mediated gene transfer of human GAA at 1 month and their neurologic, neuromuscular, and cardiac function was assessed for 1 year. We demonstrate a significant functional neurologic correction in treated animals from 4 months onward, a neuromuscular improvement from 9 months onward, and a correction of the hypertrophic cardiomyopathy at 12 months. The regions most affected by the disease i.e. the brainstem, spinal cord, and the left cardiac ventricular wall all show enzymatic, biochemical and histological correction. Muscle glycogen storage is not affected by the treatment, thus suggesting that the restoration of muscle functionality is directly related to the CNS correction. This unprecedented global and long-term CNS and cardiac cure offer new perspectives for the management of patients.
Liste complète des métadonnées

Littérature citée [73 références]  Voir  Masquer  Télécharger
Déposant : Migration Prodinra <>
Soumis le : mardi 26 mai 2020 - 06:04:03
Dernière modification le : mardi 21 juillet 2020 - 14:22:01


2017_Hordeaux_Acta neuropathol...
Fichiers éditeurs autorisés sur une archive ouverte


Distributed under a Creative Commons Paternité 4.0 International License




Juliette Hordeaux, Laurence Dubreil, Cynthia Robeveille, Johan Deniaud, Quentin Pascal, et al.. Long-term neurologic and cardiac correction by intrathecal gene therapy in Pompe disease. Acta Neuropathologica Communications, BioMed Central part of Springer Science, 2017, 5, ⟨10.1186/s40478-017-0464-2⟩. ⟨hal-02622569⟩



Consultations de la notice


Téléchargements de fichiers